ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(14), P. 10288 - 10301
Published: April 1, 2024
Insufficient
reactive
oxygen
species
(ROS)
production
and
radioresistance
have
consistently
contributed
to
the
failure
of
radiotherapy
(RT).
The
development
a
biomaterial
capable
activating
ROS-induced
apoptosis
ferroptosis
is
potential
strategy
enhance
RT
sensitivity.
To
achieve
precision
high-efficiency
RT,
theranostic
nanoplatform
Au/Cu
nanodots
(Au/CuNDs)
were
designed
for
dual-mode
imaging,
amplifying
ROS
generation,
inducing
apoptosis-ferroptosis
sensitize
RT.
A
large
amount
derived
from
three
aspects:
(1)
When
exposed
ionizing
radiation,
Au/CuNDs
effectively
absorb
photons
emit
various
electrons,
which
can
interact
with
water
produce
ROS.
(2)
act
as
catalase-like
abundant
through
Fenton
reaction
hydrogen
peroxide
overexpressed
tumor
cells.
(3)
deplete
glutathione,
causes
accumulation
Large
amounts
radiation
further
lead
by
increasing
DNA
damage,
enhancing
lipid
peroxidation,
significantly
improving
therapeutic
efficiency
Furthermore,
serve
an
excellent
nanoprobe
high-resolution
near-infrared
fluorescence
imaging
computed
tomography
tumors.
promising
performance
shows
their
application
in
clinical
cancer
detection
imaging-guided
minimizing
damage
adjacent
normal
tissues
during
In
summary,
our
developed
integrates
sensitizes
via
ROS-activated
apoptosis-ferroptosis,
offering
prospect
diagnosis
treatment.
Chemical Society Reviews,
Journal Year:
2021,
Volume and Issue:
50(15), P. 8669 - 8742
Published: Jan. 1, 2021
Inorganic
nanomaterials
that
have
inherently
exceptional
physicochemical
properties
(e.g.,
catalytic,
optical,
thermal,
electrical,
or
magnetic
performance)
can
provide
desirable
functionality
drug
delivery,
diagnostics,
imaging,
therapy)
considerable
potential
for
application
in
the
field
of
biomedicine.
However,
toxicity
be
caused
by
long-term,
non-specific
accumulation
these
inorganic
healthy
tissues,
preventing
their
large-scale
clinical
utilization.
Over
past
several
decades,
emergence
biodegradable
and
clearable
has
offered
to
prevent
such
long-term
toxicity.
In
addition,
a
comprehensive
understanding
design
metabolic
pathways
within
body
is
essential
enabling
expansion
theranostic
applications
various
diseases
advancing
trials.
Thus,
it
critical
importance
develop
biomedical
applications.
This
review
systematically
summarizes
recent
progress
nanomaterials,
particularly
cancer
theranostics
other
disease
therapies.
The
future
prospects
opportunities
this
rapidly
growing
are
also
discussed.
We
believe
timely
will
stimulate
guide
additional
in-depth
studies
area
nanomedicine,
as
rapid
vivo
clearance
degradation
likely
prerequisite
translation
with
unique
functionality.
Nature Communications,
Journal Year:
2019,
Volume and Issue:
10(1)
Published: March 25, 2019
Abstract
Lithium
metal
batteries
have
been
considerably
limited
by
the
problems
of
uncontrolled
dendritic
lithium
formation
and
highly
reactive
nature
with
electrolytes.
Herein,
we
developed
functional
porous
bilayer
composite
separators
simply
blade-coating
polyacrylamide-grafted
graphene
oxide
molecular
brushes
onto
commercial
polypropylene
separators.
Our
integrate
lithiophilic
feature
hairy
polyacrylamide
chains
fast
electrolyte
diffusion
pathways
excellent
mechanical
strength
nanosheets
thus
enable
molecular-level
homogeneous
ionic
flux
on
surfaces
electrodes.
As
a
result,
dendrite-free
uniform
deposition
high
Coulombic
efficiency
(98%)
ultralong-term
reversible
plating/stripping
(over
2600
h)
at
current
density
(2
mA
cm
−2
)
are
achieved
for
anodes.
Remarkably,
anodes
an
unprecedented
stability
more
than
1900
h
cycling
ultrahigh
20
demonstrated.
ACS Nano,
Journal Year:
2021,
Volume and Issue:
15(5), P. 8039 - 8068
Published: May 11, 2021
Cancer
cells
frequently
exhibit
resistance
to
various
molecular
and
nanoscale
drugs,
which
inevitably
affects
the
drugs'
therapeutic
outcomes.
Overexpression
of
glutathione
(GSH)
has
been
observed
in
many
cancer
cells,
solid
evidence
corroborated
resulting
tumor
a
variety
anticancer
therapies,
suggesting
that
this
biochemical
characteristic
can
be
developed
as
potential
target
for
treatments.
The
single
treatment
GSH-depleting
agents
potentiate
responses
different
cell
death
stimuli;
therefore,
an
adjunctive
strategy,
GSH
depletion
is
usually
combined
with
mainstream
therapies
enhancing
Propelled
by
rapid
development
nanotechnology,
readily
constructed
into
nanomedicines,
have
shown
steep
rise
over
past
decade.
Here,
we
review
common
nanomedicines
widely
applied
synergistic
treatments
recent
years.
Some
current
challenges
future
perspectives
depletion-based
are
also
presented.
With
understanding
structure–property
relationship
action
mechanisms
these
biomaterials,
hope
nanotechnology
will
further
realize
more
effective
disease
even
achieve
successful
clinical
translations.
International Journal of Nanomedicine,
Journal Year:
2020,
Volume and Issue:
Volume 15, P. 9407 - 9430
Published: Nov. 1, 2020
Abstract:
The
rapid
development
of
nanotechnology
offers
a
variety
potential
therapeutic
strategies
for
cancer
treatment.
High
atomic
element
nanomaterials
are
often
utilized
as
radiosensitizers
due
to
their
unique
photoelectric
decay
characteristics.
Among
them,
gold
nanoparticles
(GNPs)
one
the
most
widely
investigated
and
considered
be
an
ideal
radiotherapy
high
X-ray
absorption
physicochemical
properties.
Over
last
few
decades,
multi-disciplinary
studies
have
focused
on
design
optimization
GNPs
achieve
greater
dosing
capability
higher
effects
highlight
mechanisms
radiosensitization
GNPs.
Although
radiosensitizing
has
been
recognized,
its
clinical
translation
still
faces
many
challenges.
This
review
analyses
different
roles
in
summarizes
recent
advances.
In
addition,
underlying
GNP
radiosensitization,
including
physical,
chemical
biological
discussed,
which
may
provide
new
directions
transformation
next-generation
Keywords:
nanoparticles,
radiotherapy,
Nano Convergence,
Journal Year:
2021,
Volume and Issue:
8(1)
Published: Nov. 2, 2021
Modern
medicine
has
been
waging
a
war
on
cancer
for
nearly
century
with
no
tangible
end
in
sight.
Cancer
treatments
have
significantly
progressed,
but
the
need
to
increase
specificity
and
decrease
systemic
toxicities
remains.
Early
diagnosis
holds
key
improving
prognostic
outlook
patient
quality
of
life,
diagnostic
tools
are
cusp
technological
revolution.
Nanotechnology
steadily
expanded
into
reaches
chemotherapy,
radiotherapy,
diagnostics,
imaging,
demonstrating
capacity
augment
each
advance
care.
Nanomaterials
provide
an
abundance
versatility,
functionality,
applications
engineer
specifically
targeted
medicine,
accurate
early-detection
devices,
robust
imaging
modalities,
enhanced
radiotherapy
adjuvants.
This
review
provides
insights
current
clinical
pre-clinical
nanotechnological
drug
therapy,
radiation
therapy.
Advanced Materials,
Journal Year:
2021,
Volume and Issue:
33(24)
Published: May 5, 2021
Abstract
Radioresistance
is
an
important
challenge
for
clinical
treatments.
The
main
causes
of
radioresistance
include
hypoxia
in
the
tumor
microenvironment,
antioxidant
system
within
cancer
cells,
and
upregulation
DNA
repair
proteins.
Here,
a
multiple
radiosensitization
strategy
high‐
Z
‐element‐based
radiation
enhancement
designed,
attenuating
microRNA
therapy.
novel
2D
graphdiyne
(GDY)
can
firmly
anchor
disperse
CeO
2
nanoparticles
to
form
GDY–CeO
nanocomposites,
which
exhibit
superior
catalase‐mimic
activity
decomposing
H
O
significantly
alleviate
hypoxia,
promote
radiation‐induced
damage,
ultimately
inhibit
growth
vivo.
miR181a‐2‐3p
(miR181a)
serum
levels
patients
are
predictive
response
preoperative
radiotherapy
locally
advanced
esophageal
squamous
cell
carcinoma
(ESCC)
facilitate
personalized
treatment.
Moreover,
miR181a
act
as
radiosensitizer
by
directly
targeting
RAD17
regulating
Chk2
pathway.
Subsequently,
nanocomposites
with
conjugated
iRGD‐grafted
polyoxyethylene
glycol
(short
nano‐miR181a),
increase
stability,
efficiently
deliver
tumor,
low
toxicity.
Notably,
nano‐miR181a
overcome
enhance
therapeutic
efficacy
both
subcutaneous
model
human‐patient‐derived
xenograft
models.
Overall,
this
nanozyme
miR181a‐based
multisensitized
provides
promising
approach
ESCC.
ACS Nano,
Journal Year:
2019,
Volume and Issue:
13(5), P. 5947 - 5958
Published: April 10, 2019
Despite
the
development
of
nanomaterials
with
high-Z
elements
for
radiosensitizers,
most
them
suffer
from
their
oxygen-dependent
behavior
in
hypoxic
tumor,
nonideal
selectivity
to
or
inevasible
damages
normal
tissue,
greatly
limiting
further
applications.
Herein,
we
develop
a
Schottky-type
heterostructure
Au-Bi2S3
promising
ability
reactive
free
radicals
generation
under
X-ray
irradiation
selectively
enhancing
radiotherapeutic
efficacy
by
catalyzing
intracellular
H2O2
tumor.
On
one
hand,
like
many
other
rich
elements,
can
deposit
higher
radiation
dose
within
tumors
form
high
energy
electrons.
remarkably
improve
utilization
large
number
X-ray-induced
low
electrons
during
radiotherapy
nonoxygen
dependent
even
condition.
This
feature
heterostructures
attributes
generated
Schottky
barrier
between
metal
Au
and
semiconductor
Bi2S3,
which
trap
X-ray-generated
transfer
Au,
resulting
efficient
separation
electron-hole
pairs.
Then,
because
matched
potential
conduction
band
Bi2S3
overexpressed
HNSCs
decompose
into
highly
toxic
•OH
selective
radiosensitization
As
consequence,
this
kind
nanoparticle
provides
an
idea
rational
designed
as
radiosensitizers
enhanced
cancer.
Abstract
Until
now,
enormous
smart
materials
have
been
engineered
with
endogenous
stimulators
such
as
pH,
reactive
oxygen
species,
glutathione,
hypoxia
and
enzyme,
or
exogenous
temperature,
light,
ultrasound,
radiation,
magnetic
field
in
drug
delivery.
As
footstone
of
stimuli‐responsive
nanocarriers,
endogenous/exogenous
responsive
possess
many
properties,
responding
ability
to
specific
triggers,
controlled
release,
long
blood
circulation,
increased
tumor
accumulation,
“ON‐OFF”
switch
activities,
enhanced
diagnostic
accuracy,
therapeutic
efficacy.
Smart
attracted
considerable
attention
because
they
provide
likelihood
strategy
for
individualized
comprehensive
therapy.
In
this
review,
significant
research
achievements
different
triggers
including
their
synthesis
formulation
mechanism,
applications,
multiple
functions
are
summarized
discussed
separately.
We
primarily
focus
on
the
studies
past
few
years
(2017‐2020).
The
current
situation
remaining
challenges
stimuli‐sensitive
materials‐based
nanocarriers
clinical
translation
rationally
at
end.
It
is
hope
that
timely
overall
review
would
some
helpful
information
researchers
field.